Carisma Therapeutics to Present at Upcoming April 2024 Conferences

03 Apr 2024
www.biospace.com
ImmunotherapyCell Therapy
PHILADELPHIA, April 3, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that it will present at the following upcoming conferences: Needham 23rd Annual Virtual Healthcare Conference Steven Kelly, President and Chief Executive Officer, will give a corporate presentation. Wednesday, April 10 at 3:45 PM ET Virtual Chardan 8th Annual Genetic Medicines & Cell Therapy Manufacturing Summit Steven Kelly, President and Chief Executive Officer, will give a corporate presentation. Monday, April 29 at 2:00 PM ET Virtual Live webcasts will be available on the Company's Investor Events webpage. A replay of the webcasts, when available, will be archived for a limited time following each event. About Carisma Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit . Investors: Shveta Dighe Head of Investor Relations investors@carismatx.com View original content to download multimedia: SOURCE Carisma Therapeutics Inc. Company Codes: NASDAQ-NMS:CARM
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.